Posts Tagged ‘ICOF’

Categories

Posted in:

Tuesday May 24th, 2016

Diagnosis through the retina can predict the evolution of patients with Multiple Sclerosis

A study led by IDIBAPS researchers has shown the usefulness of optical coherence tomography (OCT), a diagnostic imaging technique widely used in ophthalmology, for monitoring patients with multiple sclerosis (MS). The analysis of the retina with this technique can determine the risk of clinical worsening of those patients. Dr. Pablo Villoslada, head of the IDIBAPS Pathogenesis and new treatments in Multiple Sclerosis, and Dr. Elena H. Martinez-Lapiscina, researcher of the same group and head of the Visual Pathway Lab, coordinate this article published in The Lancet Neurology. Researchers from centers in Spain, Italy, France, Germany, Czech Republic, Holland, Canada and the United States have been involved in this study.

Read the rest of this entry »

Comments Closed
Tuesday May 17th, 2016

Researchers from the IDIBAPS discover the role of an inflammatory protein in age-related macular degeneration

Researchers from IDIBAPS have taken part in a study that delves into the role of C-reactive protein –an inflammation marker– in age-related macular degeneration (AMD). They have shown using in vitro studies that, that the monomeric form of the C-reactive protein contributes to the inflammatory process associated to DMAE. Dr. Blanca Molins has coordinated the study published in the Scientific Reports journal. She is a researcher at the Laboratory of Ocular Inflammation and Immunology at the Institut Clinic d’Oftalmologia (ICOF), in Hospital Clinic and IDIBAPS, led by Dr. Alfredo Adan.

Read the rest of this entry »

Comments Closed